Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
clinical trials
drugs
4
×
life sciences
national blog main
new york blog main
new york top stories
regeneron pharmaceuticals
4
×
biotech
boston top stories
fda
national top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
alnylam pharmaceuticals
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
rna interference
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
89bio
abbvie
adrian krainer
age related macular degeneration
agios pharmaceuticals
akcea therapeutics
What
alnylam
drug
rna
week
ago
alzheimer’s
american
annual
approve
ash
assessed
attention
awaits
based
big
bio
biological
biotech
blood
cholesterol
communities
conference
country
crossed
data
decades
decision
diego
discovered
disease
esmo
europe
evidence
fda
fingers
friday
gathering
germany
heart
hematology’s
Language
Current search:
drugs
×
" regeneron pharmaceuticals "
×
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
